RESMED INC — Director's Dealing 2018

Jun 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-05-30

Reporting Person: SULPIZIO RICHARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-30	ResMed Common Stock	M	28403	$27.58	Acquired	35823	Direct
2018-05-30	ResMed Common Stock	S	28403	$102.78	Disposed	7420	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-30	ResMed Common Stock Options	$27.58	M	28403	Disposed	2018-11-16	ResMed Commmon Stock (28403)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $102.48 to $103.17. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F2: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.